Serine 32 and serine 36 of IκBα are directly phosphorylated by protein kinase CKII in vitro

Journal of Molecular Biology

Volumn 290, Issue 4, 1999, Pages 839-850

  Taylor, Julie A ^a   Bren, Gary D ^a   Pennington, Kevin N ^a   Trushin, Sergey A ^a   Asin, Susana ^a   Paya, Carlos V ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

IKK; I B; Monocytes; NF B; PK CKII

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; NUCLEAR FACTOR KAPPA B INHIBITOR PROTEIN; PHOSPHOSERINE; PROTEIN SERINE THREONINE KINASE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 0032811045     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2912     Document Type: Article

References (73)

1. Allende J. E., Allende C. C. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB J. 9:1995;313-323.
2. Baeuerle P. A., Baltimore D. IκB: a specific inhibitor of the NFκB transcription factor. Science. 242:1988;540-546.
3. Baeuerle P. A., Baltimore D. A 65-kD subunit of active NFκB is required for inhibition of NFκB by IκB. Genes Dev. 3:1989;1689-1698.
4. Baeuerle P. A., Baltimore D. NFκB: ten years after. Cell. 87:1996;13-20.
5. Baeuerle P. A., Henkel T. Function and activation of NFκB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
6. Baichwal V. R., Baeuerle P. A. Activate NFκB or die? Curr. Biol. 7:1997;R94-96.
7. Baldi L., Brown K., Franzoso G., Siebenlist U. Critical role for lysines 21 and 22 in signal-induced ubiquitin-mediated proteolysis of IκBα J. Biol. Chem. 271:1996;376-379.
8. Barroga C. F., Stevenson J. K., Schwarz E. M., Verma I. M. Constitutive phosphorylation of IκBα by casein kinase II. Proc. Natl Acad. Sci. USA. 92:1995;7637-7641.
9. Beg A. A., Baltimore D. An essential role for NFκB in preventing TNF-alpha-induced cell death. Science. 274:1996;782-784.
10. Beg A. A., Ruben S. M., Scheinman R. I., Haskill S., Rosen C. A., Baldwin A. S. IκB interacts with the nuclear localization sequences of the subunits of NFκB: a mechanism for cytoplasmic retention. Genes Dev. 6:1992;1899-1913.
11. Beg A. A., Finco T. S., Nantermet P. V., Baldwin A. S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism of NFκB activation. Mol. Cell. Biol. 13:1993;3301-3310.
12. Beg A. A., Sha W. C., Bronson R. T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NFκB. Nature. 376:1995;167-170.
13. Brockman J. A., Scherer D. C., McKinsey T. A., Hall S. M., Qi X., Lee W. Y., Ballard D. W. Coupling of a signal response domain in IκBα to multiple pathways for NFκB activation. Mol. Cell. Biol. 15:1995;2809-2818.
14. Brown K., Park S., Kanno T., Franzoso G., Siebenlist U. Mutual regulation of the transcriptional activator NFκB and its inhibitor, IκBα Proc. Natl Acad. Sci. USA. 90:1993;2532-2536.
15. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1995;1485-1488.
16. Chen Z., Hagler J., Palombella V. J., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteosome pathway. Genes Dev. 9:1995;1586-1597.
17. Chen Z. J., Parent L., Maniatis T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
18. Chen-Wu J. L., Padmanabha R., Glover C. V. Isolation, sequencing, and disruption of the CKA1 gene encoding the alpha subunit of yeast casein kinase II. Mol. Cell. Biol. 8:1988;4981-4990.
19. Chester N., Yu I. J., Marshak D. R. Identification and characterization of protein kinase CKII isoforms in HeLa cells. J. Biol. Chem. 270:1995;7501-7514.
20. Chu Z. L., McKinsey T. A., Liu L., Gentry J. J., Malim M. H., Ballard D. W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 in under NFκB control. Proc. Natl Acad. Sci. USA. 94:1997;10057-10062.
21. Cordle S. R., Donald R., Read M. A., Hawiger J. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-rel and related NFκB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:1993;11803-11810.
22. Diaz-Meco M. T., Dominguez I., Sanz L., Dent P., Lozano J., Municio M. M., Berra E., Hay R. T., Sturgill T. W., Moscat J. ζPKC induces phosphorylation and inactivation of IκBα in vitro. EMBO J. 13:1994;2842-2848.
23. DiDonato J. A., Mercurio F., Karin M. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NFκB. Mol. Cell. Biol. 15:1995;1302-1311.
24. DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., Karin M. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1996;1295-1304.
25. DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NFκB. Nature. 388:1997;548-554.
26. Frankenberger M., Pforte A., Sternsdorf T., Passlick B., Baeuerle P. A., Ziegler-Heitbrock H. W. Constitutive nuclear NFκB in cells of the monocyte lineage. Biochem. J. 304:1994;87-94.
27. Frantz B., Nordby E. C., Bren G., Steffan N., Paya C. V., Kincaid R. L., Tocci M. J., O'Keefe S. J., O'Neill E. A. Calcineurin acts in synergy with PMA to inactivate IκBMAD3, an inhibitor of NFκB. EMBO J. 13:1994;861-870.
28. rsk) phosphorylates the N-terminal regulatory domain of IκBα and stimulates its degradation in vitro. J. Biol. Chem. 272:1997;21281-21288.
29. Ghosh S., Baltimore D. Activation in vitro of NFκB by phosphorylation of its inhibitor IκB. Nature. 344:1990;678-682.
30. Gilmore T. D., Koedood M., Piffat K. A., White D. W. Rel/NFκB/IκB proteins and cancer. Oncogene. 13:1996;1367-1378.
31. Haskill D., Beg A. A., Tompkins S. M., Morris J. S., Yurochko A. D., Sampson-Johannes A., Mondal K., Ralph P., Baldwin A. S. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell. 65:1991;1281-1289.
32. Hathaway G. M., Traugh J. A. Casein kinases - multipotential protein kinases. Curr. Top. Cell. Reg. 21:1982;101-127.
33. Hathaway G. M., Lubben T. H., Traugh J. A. Inhibition of casein kinase II by heparin. J. Biol. Chem. 255:1980;8038-8041.
34. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., Baeuerle P. A. Rapid proteolysis of IκBα is necessary for activation of transcription factor NFκB. Nature. 365:1993;182-185.
35. Herrero J. A., Mathew P., Paya C. V. LMP-1 activates NFκB by targeting the inhibitory molecule IκBα J. Virol. 69:1995;2168-2174.
36. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
37. Kieran M., Blank V., Logeat F., Vandekerckhove J., Lottspeich F., Le Bail O., Urban M. B., Kourilsky P., Baeuerle P. A., Israel A. The DNA binding subunit of NFκB is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1990;1007-1018.
38. Krappmann D., Wulczyn F. G., Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NFκB inhibitor IκBα in vivo. EMBO J. 15:1996;6716-6726.
39. Lee F. S., Hagler J., Chen Z. J., Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
40. Lee F. S., Peters R. T., Dang L. C., Maniatis T. MEKK1 activates both IκB kinase α and IκB kinase β Proc. Natl Acad. Sci. USA. 95:1998;9319-9324.
41. Lin R., Beauparlant P., Makris C., Meloche S., Hiscott J. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16:1996;1401-1409.
42. Mattson M. P., Goodman Y., Luo H., Fu W., Furukawa K. Activation of NFκB protects hippocampal neurons against oxidative stress-induced apoptosis:evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49:1997;681-697.
43. McElhinny J. A., MacMorran W. S., Bren G. D., Ten R. M., Israel A., Paya C. V. Regulation of IκBα and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J. Virol. 69:1995;1500-1509.
44. McElhinny J. A., Trushin S. A., Bren G. D., Chester N., Paya C. V. Casein kinase II phosphorylates IκBα at S-283, S-288, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16:1996;899-906.
45. Meggio F., Marin O., Pinna L. A. Substrate specificity of protein kinase CK2. Cell. Mol. Biol. Res. 40:1994;401-409.
46. Mercurio F., DiDonato J. A., Rosette C., Karin M. p105 and p98 precursor proteins play an active role in NFκB-mediated signal transduction. Genes Dev. 7:1993;705-718.
47. Mercurio F., Zhu H., Murray B. W., Shevchenko A., Bennett B. L., Wu Li J., Young D. B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NFκB activation. Science. 278:1997;860-866.
48. Miyamoto S., Chiao P. J., Verma I. M. Enhanced IκBα degradation is responsible for constitutive NFκB activity in mature murine B-cell lines. Mol. Cell. Biol. 14:1994;3276-3282.
49. Nolan G. P., Ghosh S., Liou H.-C., Tempst P., Baltimore D. DNA binding and IκB inhibition of the cloned p65 subunit of NFκB, a rel related polypeptide. Cell. 64:1991;961-969.
50. Padmanabha R., Chen-Wu J. L.-P., Hanna D. E., Glover C. V. C. Isolation, sequencing and disruption of the yeast CKA2 gene: casein kinase II is essential for viability in Saccharomyces cerevisiae. Mol. Cell. Biol. 10:1990;4089-4099.
51. Pierce J. W., Schoenleber R., Jesmok G., Best J., Moore S. A., Collins T., Gerritsen M. E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:1997;21096-21103.
52. Pinna L. A., Meggio F. Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation. Prog. Cell Cycle Res. 3:1997;77-97.
53. Pinna L. A., Ruzzene M. How do protein kinases recognize their substrates. Biochim. Biophys. Acta. 1314:1996;191-225.
54. Rénier C. H., Song H. Y., Gao X., Goeddel D. V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
55. Rice N. R., Ernst M. K. In vivo control of NFκB activation by IκBα EMBO J. 12:1994;4685-4695.
56. Schouten G. J., Vertegaal A. C. O., Whiteside S. T., Israel A., Toebes M., Dorsman J. C., van der Eb A. J., Zantema A. IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:1997;3133-3144.
57. Schwarz E. M., Van Antwerp D., Verma I. M. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine-293: requirement for degradation of free IκBα Mol. Cell. Biol. 16:1996;3554-3559.
58. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716.
59. Shao R., Karunagaran D., Zhou B. P., Li K., Lo S. S., Deng J., Chiao P., Hung M. C. Inhibition of NFκB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J. Biol. Chem. 272:1997;32739-32742.
60. Sharma H. W., Narayanan R. The NFκB transcription factor in oncogenesis. Anticancer Res. 16:1996;589-596.
61. Shirakawa F., Mizel S. B. In vitro activation and nuclear translocation of NFκB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:1989;2424-2430.
62. Sun S.-C., Ganchi P. A., Ballard D. W., Greene W. C. NFκB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science. 259:1993;1912-1915.
63. Sun S.-C., Elwood J., Beraud C., Greene W. C. Human T cell leukemia type I tax activation of NFκB/rel involves phosphorylation and degradation of IκBα and relA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol. 14:1994a;7377-7384.
64. Sun S.-C., Ganchi P. A., Beraud C., Ballard D. W., Greene W. C. Autoregulation of the NFκB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl Acad. Sci. USA. 91:1994b;1346-1350.
65. Sun S.-C., Elwood J., Greene W. C. Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol. 16:1996;1058-1065.
66. Thompson J. E., Phillips R. J., Bromage H. E-., Tempst P., Ghosh S. IκBβ regulates the persistent response in a biphasic activation of NFκB. Cell. 80:1995;573-582.
67. Traenckner E. B.-M., Wilk S., Baeuerle P. A. A proteosome inhibitor prevents activation of NFκB and stabilizes a newly phosphorylated form of IκBα that is still bound to NFκB. EMBO J. 13:1994;5433-5441.
68. Traenckner E. B.-M., Pahl H. L., Henkel T., Schmidt K. N., Wilk S., Baeuerle P. A. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NFκB activation in response to diverse stimuli. EMBO J. 14:1995;2876-2883.
69. Van Antwerp D. J., Verma I. M. Signal-induced degradation of IκBα: association with NFκB and the PEST sequence in IκBα are not required. Mol. Cell. Biol. 16:1996;6037-6045.
70. Whiteside S. T., Ernst M. K., LeBail O., Laurent-Winter C., Rice N., Israel A. N- and C-terminal sequences control degradation of MAD3/IκBα in response to inducers of NFκB activity. Mol. Cell. Biol. 15:1995;5339-5345.
71. Woronicz J. D., Gao X., Cao Z., Rothe M., Goeddel D. V. IκB kinase-β: NFκB activation and complex formation with IκB kinase-α and NIK. Science. 278:1997;866-869.
72. Zandi E., Torhwarf D. M., Delhase M., Hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NFκB activation. Cell. 91:1997;243-252.
73. Zechner D., Craig R., Hanford D. S., McDonough P. M., Sabbadini R. A., Glembotski C. C. MKK6 activates myocardial cell NFκB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J. Biol. Chem. 273:1998;8232-8239.